arXiv preprint ·

Deep learning for non-transvenous ICD screening: tailored neural network architectures, extended experiments, and explainability

Bartosz Morawski, Samuel J. Ward, Alex Touze, Lin-Thiri Toon, Paul R. Roberts, John Paisey and Alain B. Zemkoho

Published
Source
arXiv preprint, posted before peer review
Original
Read it at arXiv
Topics
Machine Learning

Abstract

This paper studies two non-transvenous implantable cardioverter-defibrillators (ICDs), namely the Subcutaneous ICD (S-ICD) and the Extravascular ICD (EV-ICD). Both avoid the complications of transvenous leads but are prone to oversensing, which can trigger inappropriate shocks associated with increased mortality. Oversensing risk is predicted by the ratio of T- or P-wave amplitude to R-wave amplitude (T:R, P:R), and these ratios vary over a 24-hour period. Yet S-ICD screening uses a single 10-second electrocardiogram (ECG) segment, and the EV-ICD has no formal screening protocol whatsoever. We present a 24-hour ambulatory screening framework for both devices which includes the first T:R analysis in an EV-ICD cohort and the first full evaluation of P:R prediction. We introduce AmpRatioNet, a family of 1D convolutional neural network architectures operating directly on the ECG signal, and benchmark it against the best existing approach - based on 2D phase space reconstruction images. Evaluation uses 4,605 clinician-annotated 10-second segments from 89 patients, with patient-level 10-fold cross-validation and bootstrap confidence intervals. AmpRatioNet-SE demonstrates superior performance on every metric in each setting with no device- or ratio-specific redesign. An explainability analysis against interpretable classical peak labelling algorithms shows that AmpRatioNet-SE's increase in error on oversensing-prone segments is up to 14 times smaller than theirs. Segment-level predictions are aggregated into a 24-hour timeline, extending S-ICD screening beyond 10 seconds and offering a plausible EV-ICD screening pathway pending device-level validation.

The authors’ abstract, as arXiv lists it. arXiv’s listings, abstracts included, are free for anyone to reuse.

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Machine Learning

Get the few papers worth your time in Machine Learning every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics